Dr Reddy’s Q4 profit dips 29 pc to Rs 557 cr Net sales however rose to Rs 4,608 crore in the quarter under review as compared with Rs 4,336.1 crore in… May 14, 2021 14:57 IST
Dr Reddy’s Laboratories rating – Buy: API supplies for Vascepa are an issue Gradual ramp-up of drug expected through FY22, with US revenues of $25 m; FY22e EPS down 1%; ‘Buy’ retained with… March 16, 2021 02:45 IST
Dr Reddy’s and TR-Pharm in agreement TR-Pharm will manufacture the drug substance and drug product upon completion of its facility investment in Turkey March 11, 2016 15:33 IST
Dr Reddy’s gets USFDA nod for migraine injection The company has received an approval from the US Food and Drug Administration (USFDA) for ZembraceSymTouch injection, DRL said in… January 29, 2016 17:25 IST
Pharma investors think small as US compliance woes hit heavyweights Investors in India’s $15 billion pharmaceutical industry are favouring smaller firms with little or no exposure to the United States. December 22, 2015 18:01 IST
Dr Reddy’s gets USFDA extension for its response The US Food and Drug Administration (USFDA) has granted Dr Reddy’s Laboratories extension till December 7 for submitting its responses… November 27, 2015 00:47 IST
Retain ‘buy’ on Dr Reddy’s, target Rs 4,919: Nomura Retain ‘buy’ on Dr Reddy’s Laboratories and assign a target price of R 4,919 per share, valuing the stock at… November 27, 2015 00:11 IST
USFDA gives Dr Reddy’s additional time to respond to warning letter Dr Reddy’s Laboratories Ltd (DRL) today said the USFDA has extended the time-frame for replying to the warning letter issued… November 26, 2015 17:49 IST
USFDA warns of serious data integrity violations at Dr Reddy’s The US Food and Drug Administration (USFDA) has warned Dr Reddy’s Laboratories over serious data integrity violations, placing all its… November 26, 2015 01:04 IST
Dr Reddy’s launches Nise D Spray The spray will likely be effective in reducing inflammation and pain November 3, 2015 17:00 IST
Dr Reddy’s launches Nexium generic in US market Dr Reddy’s Laboratories (DRL) has launched the generic version of Astrazeneca’s Nexium, used to treat acid reflux, in the US… September 28, 2015 13:07 IST
Dr Reddy’s in pact with Australia firm Dr Reddy’s Laboratories has signed a deal with Australian pharmaceutical company Hatchtech, to develop Xeglyze lotion… September 15, 2015 00:52 IST
Dr. Reddy’s in pact to sell Hatchtech hair lice lotion Dr. Reddy’s Laboratories on Monday said it has signed a deal with Hatchtech, an Australian pharmaceutical company to sell the… Updated: September 14, 2015 16:30 IST
Dr Reddy’s recalls Rivastigmine Tartrate capsules from US Dr Reddy’s Laboratories (DRL) has initiated voluntary recall of Rivastigmine Tartrate Capsules of 1.5 mg strength from the USA market,… Updated: August 20, 2015 16:51 IST
Dr Reddy’s Q1 net up 14% at Rs 626 crore Drug major Dr Reddy’s Laboratories today reported a 13.67 per cent rise in its consolidated net profit to Rs 625.65… July 30, 2015 15:33 IST
DRL unveils new corporate brand identity The new identity speaks of Dr Reddy’s constant endeavour to understand the unmet and under-met needs of patients, and the… Updated: July 2, 2015 11:22 IST
e-Passport launched in India: Who can apply, how to apply, application fee, benefits, key security upgrades and more
Who is Alexandr Wang? 28-year-old hired for 14 billion US dollar by Mark Zuckerberg to lead Meta superintelligence labs
‘IndiGo crisis pre-planned,’ alleges pilots’ body president, says management needs to be fined, criminally prosecuted